Thomas Lynch

Thomas Lynch

Direktor/Vorstandsmitglied bei FOGHORN THERAPEUTICS INC.

Vermögen: 613 334 $ am 31.08.2026

65 Jahre
Health Services
Commercial Services
Health Technology

Profil

Thomas James Lynch is currently President & Director at Fred Hutchinson Cancer Center since 2020.
Director at The Schwartz Center for Compassionate Healthcare since 2014.
Independent Director at Foghorn Therapeutics, Inc. since 2022.
Non-Executive Director at Hummingbird Bioscience Pte Ltd. since 2021.
Independent Director at Natera, Inc. starting 2026.
Member of American Society of Clinical Oncology, Inc., International Association for the Study of Lung Cancer, Washington State Academy of Sciences, and American Association for Cancer Research.
Former roles include Chairman & Chief Executive Officer at Massachusetts General Physician's Organization, Inc. from 2015 to 2017.
Chairman at Kleo Pharmaceuticals, Inc. from 2019 to 2020.
Independent Director at Infinity Pharmaceuticals, Inc. from 2012 to 2014.
Director & Professor at Yale Cancer Center from 2009 to 2015.
Director at The Massachusetts General Hospital from 2015 to 2017.
Director at PearlPoint Cancer Support, Inc. Chief Scientific Officer & Executive VP at Bristol Myers Squibb Co. from 2017 to 2019.
Chief-Oncology Hematology at The General Hospital Corp.
from 2007 to 2009.
Professor-Medicine at Harvard Medical School from 2008 to 2009.
Professor at Yale School of Medicine from 2009 to 2015.
Education includes a doctorate from Yale University.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
26.06.2026 1’905 ( 0% ) 613 334 $ 31.08.2026
24.06.2026 0 ( -.--% ) - $ 31.08.2026

Aktive Positionen von Thomas Lynch

UnternehmenPositionBeginn
FOGHORN THERAPEUTICS INC. Direktor/Vorstandsmitglied 27.10.2022
NATERA, INC. Direktor/Vorstandsmitglied 03.06.2026
Corporate Officer/Principal -
Direktor/Vorstandsmitglied 26.07.2021
Präsident 01.01.2020
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
The Schwartz Center for Compassionate Healthcare
Direktor/Vorstandsmitglied -

Ehemalige bekannte Positionen von Thomas Lynch

UnternehmenPositionEnde
░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Thomas Lynch im Detail an

Ausbildung von Thomas Lynch

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

83

Beziehungen ersten Grades

21

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen21

Health Technology

Health Services

Health Technology

Consumer Services

Health Services

Commercial Services

Commercial Services

Health Services

Health Services

Health Services

Health Technology

Commercial Services

Commercial Services

Health Services

Consumer Services

The Schwartz Center for Compassionate Healthcare

Consumer Services

Health Technology

Commercial Services

Health Technology

Commercial Services

  1. Börse
  2. Insiders
  3. Thomas Lynch
-40 %: Die besten Tools exklusiv für Abonnenten - Ihr Schlüssel zu den Top-Investitionen der Zukunft!
T
:
:
PROFITIEREN SIE JETZT